Why TJX Companies Stock Sank Today: A Closer Look
TJX posted stronger sales, yet its stock fell. This article breaks down the numbers, the market reaction, and practic...
Week Ahead Indices To Watch
This page presents Week Ahead Indices To Watch, outlining upcoming index movements and strategic considerations for the week ahead.
23,536 articles
Circle’s Revenue Skyrockets USDC as Supply Nears $75B
Circle announced a 77% year-over-year surge in Q4 2025 revenue and a USDC supply topping $75 billion, underscoring ac...
China Just Lowest Economic Growth Target Since 1991
China unveils a restrained 2026 growth target of 4.5% to 5%, marking the lowest goal in decades as policymakers weigh...
Where Will Tesla Years Be in 5 Years?
Forecasting Tesla is never dull. This article lays out base, bull, and bear scenarios for the next five years, with a...
Cramer: Power Solutions’ Drop Opens Data Center Entry
Jim Cramer’s take on Power Solutions International’s sharp drop spotlights a potential entry point for data center-re...
CEOs Freezing Hiring While Betting Billions on AI
As AI budgets surge, a majority of CEOs are freezing hiring even as they push capital into AI. The tension between au...
APM’s Michael Banner: HECM for Purchase Struggles Now
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
Arm’s First Chip Just Sparks New AI Hardware Race
Arm Holdings unveiled its first custom processor for agentic AI workloads, triggering a sharp stock rally and signali...
NWN 2026 Earnings Transcript: Key Takeaways for Investors
NWN’s Q1 2026 results reveal how the company balances growth with profitability. This analysis breaks down the number...
Capricor's Insider Just Sold: Read the Signals for Investors
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
Clarity Survived Chaotic Senate Markup: Crypto Bill Passes
In a chaotic but decisive session, the CLARITY Act survived chaotic senate moves and cleared the Senate Banking Commi...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status